Learn more

ARSANIS BIOSCIENCES GMBH

Overview
  • Total Patents
    121
  • GoodIP Patent Rank
    12,883
  • Filing trend
    ⇩ 33.0%
About

ARSANIS BIOSCIENCES GMBH has a total of 121 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are INTRINSIC LIFESCIENCES LLC, BIOGEN INTERNAT NEUROSCIENCE GMBH and PROTHENA BIOSCIENCES LTD.

Patent filings per year

Chart showing ARSANIS BIOSCIENCES GMBHs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Nagy Eszter 98
#2 Badarau Adriana 62
#3 Rouha Harald 54
#4 Mirkina Irina 54
#5 Visram Zehra 40
#6 Guachalla Luis 37
#7 Nagy Gábor 35
#8 Battles Michael Benjamin 33
#9 Stulik Lukas 29
#10 Nagy Gabor 29

Latest patents

Publication Filing date Title
EP3497124A1 Klebsiella pneumoniae o3 specific antibodies
US2019161534A1 Anti-galactan ii monoclonal antibodies targeting klebsiella pneumoniae
WO2017064258A1 Bactericidal monoclonal antibody targeting klebsiella pneumoniae
CA3003356A1 Antibodies targeting a mannan-based o-antigen of k. pneumoniae
BR112017021830A2 "monoclonal antibody that neutralizes staphylococcus aureus, its medical or diagnostic use, a pharmaceutical or diagnostic preparation, antibody-encoding nucleic acid molecules, and a method for producing the antibody."
AU2016249837A1 Anti-staphylococcus aureus antibody combination preparation
KR20170122726A Antibodies that target the galactan-based O-antigen of Klebsiella sp.
CA2956429A1 Predicting s. aureus disease
WO2015117711A1 E. coli specific antibody sequences
AU2014368474A1 Antibodies directed against the LukGH (LukAB) toxin of Staphylococcus aureus and antibody sequences
WO2015055814A1 Cross-reactive staphylococcus aureus antibody sequences
WO2014187746A2 Generation of highly potent antibodies neutralizing the lukgh (lukab) toxin of staphylococcus aureus
WO2014111516A1 Mdr e. coli specific antibody
EP2668208A1 Cross-reactive staphylococcus aureus antibody